Home >> Life Sciences >> Healthcare

Encephalopathy - Pipeline Review, H1 2017

Published: Jun-2017 | Format: PDF | Global Markets Direct | Number of pages: 48 | Code: MRS - 139813

Encephalopathy - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Encephalopathy - Pipeline Review, H1 2017, provides an overview of the Encephalopathy (Central Nervous System) pipeline landscape.

Encephalopathy is a term for any diffuse disease of the brain that alters brain function or structure. Symptoms include seizures, difficulty speaking or swallowing, trembling, involuntary twitching and muscle weakness. Causes include traumas or injuries, genetic, liver disease, hypoxic condition, Lyme disease and organ failure.  

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Encephalopathy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Encephalopathy (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Encephalopathy (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Encephalopathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase I, Preclinical and Discovery stages are 3, 9 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Encephalopathy (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Encephalopathy (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Encephalopathy (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Encephalopathy (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Encephalopathy (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 
- The pipeline guide reviews latest news related to pipeline therapeutics for Encephalopathy (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Encephalopathy (Central Nervous System).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Encephalopathy (Central Nervous System) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Encephalopathy - Overview
Encephalopathy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Encephalopathy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Encephalopathy - Companies Involved in Therapeutics Development
Celgene Corp
Chiesi Farmaceutici SpA
Fera Pharmaceuticals LLC
GW Pharmaceuticals Plc
JS Genetics Inc
Knopp Biosciences LLC
Mithra Pharmaceuticals SA
ProThera Biologics Inc
SciFluor Life Sciences LLC
Takeda Pharmaceutical Company Ltd
Encephalopathy - Drug Profiles
Alda-1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
diazoxide - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Estetrol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GWP-42003 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
melatonin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ORP-006 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
phenobarbitol sodium - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Proteins for Hypoxic-Ischemic Brain Injury - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SF-0034 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Activate Kv7.2 for Encephalopathy, Epilepsy, Neuropathic Pain and Tinnitus - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Encephalopathy and Periventricular Leukomalacia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Stem Cell Therapy for Hematological Malignancies, Hypoxic-ischemic Encephalopathy and Solid Tumor - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TAK-935 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TRP-601 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Encephalopathy - Dormant Projects
Encephalopathy - Product Development Milestones
Featured News & Press Releases
May 12, 2017: Ovid Therapeutics to Present Preclinical Data on TAK-935/OV935 at the Antiepileptic Drug and Device Trials XIV Conference
Aug 06, 2015: GW Pharmaceuticals Receives FDA Fast Track and EMA Orphan Designations for Intravenous Cannabidiol in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy
Apr 24, 2015: GW Pharmaceuticals Receives Orphan Drug Designation From FDA for Cannabidiol for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields


Related Reports

China Hyoscine-N-Butyl Bromide Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 118 | Code : MRS-191282 | 4480

Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions. Scope of the Report: This report focuses on the Hyoscine-N-Butyl Bromide in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Segment by Manufacturers, this report covers Boehringer-Ingelheim Linnea Read more

China Polymer Ligating Clips Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 118 | Code : MRS-191281 | 4480

Polymer Ligating Clips are implantable medical devices. They are widely used in surgery for marking and ligating purposes. Scope of the Report: This report focuses on the Polymer Ligating Clips in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Segment by Manufacturers, this report covers Teleflex Grena Medtronic Kangji Medical Sunstone Sinolinks Nanova Biomaterials Market Segment by Read more

China Medical Grade Hydrogel Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 117 | Code : MRS-191280 | 4480

Hydrogel is gel-like or colloidal substances made of water and solids. Hydrogels are highly absorbent (they can contain over 90% water) natural or synthetic polymeric networks. It is widely used in medical fields, industrial fields, consumer goods etc. Scope of the Report: This report focuses on the Medical Grade Hydrogel in China market, to split the market based on manufacturers, Regions (Province), type and application. Market Segment by Manufacturers, this report covers Co Read more

China Enzyme-Linked Immunosorbent Assay (ELISA) Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 123 | Code : MRS-191279 | 4480

Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality-control check in various industries,such as ELISA application in food industry. Scope of the Report: This report focuses on the Enzyme-Linked Immunosorbent Assay (ELISA) in China market, Read more

North America Pharmaceutical Blister Packaging Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 117 | Code : MRS-191278 | 4480

Blister pack is a term for several types of pre-formed plastic packaging used for small consumer goods, foods, and for pharmaceuticals. The primary component of a blister pack is a cavity or pocket made from a formable web, usually a thermoformed plastic. This usually has a backing of paperboard or a lidding seal of aluminum foil or plastic. A blister that folds onto itself is often called a clamshell. Blister packs are useful for protecting products against external factors, such as humidi Read more

North America Disposable Dental Package Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Dec-2017 | Global Info Research | Pages : 121 | Code : MRS-191277 | 4480

This report studies the disposable dental package market, which are the one-time use dental tools. Scope of the Report: This report focuses on the Disposable Dental Package in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers TREE CFPM BTI Biotechnology Institute Blodent Kerr YIMIKATA R Read more

Europe Pharmaceutical Glass Packaging Industry Research Report 2017

Dec-2017 | Hong Chun Consult | Pages : 140 | Code : MRS-191074 | 3000

The reports shows the different types’volume and Value in different applications. The major Pharmaceutical Glass Packaging Market (including UK, Germany, Italy, France, Russia, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and applications. Market Analysis by Players Gerresheimer Nipro Schott SGD Shandong PG Opmi Rocco Bormioli Ardagh West-P Market Analysis by Regions: UK Germany France Italy Russia Benelux Spain Poland Ukraine Othe Read more

Europe Compounding Pharmacy Industry Research Report 2017

Dec-2017 | Hong Chun Consult | Pages : 140 | Code : MRS-191073 | 3000

The reports shows the different types’volume and Value in different applications. The major Compounding Pharmacy Market (including UK, Germany, Italy, France, Russia, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and applications. Market Analysis by Players Fagron Wedgewood Pharma CAPS Fresenius Kabi PharMEDium Services Cantrell Drug Advanced Pharma Dougherty's Pharmacy Institutional Pharmacy Solutions Lorraine's Pharmacy Village Com Read more

Europe Surgical Needle Industry Research Report 2017

Dec-2017 | Hong Chun Consult | Pages : 140 | Code : MRS-191072 | 3000

The reports shows the different types’volume and Value in different applications. The major Surgical Needle Market (including UK, Germany, Italy, France, Russia, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and applications. Market Analysis by Players Johnson & Johnson Medtronic B Braun Medline Smith & Nephew Peters Surgical Feuerstein Sutures India SERAG-WIESSNER Internacional Farmacéutica Aspen Surgical Wego Unimed Resorba Assut M Read more

Europe Perphenazine Industry Research Report 2017

Dec-2017 | Hong Chun Consult | Pages : 140 | Code : MRS-191071 | 3000

The reports shows the different types’volume and Value in different applications. The major Perphenazine Market (including UK, Germany, Italy, France, Russia, etc.) is analyzed, data including: market size, import and export, sale segment market by product type and applications. Market Analysis by Players Sandoz Actavis Qualitest Mylan Tianjing Lisheng Pharm Sinapharm Beijing Zhongxin Pharm Changzhou Siyao Pharm Shanghai Fuxing Pharm Market Analysis by Regions: UK Germany France Italy Rus Read more

Single User | $(USD)2000 View Pricing